Clinical trial
GSK159802 In Healthy Male Subjects And Asthmatics
NCT00364273 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00364273 |
|---|---|
| Title | GSK159802 In Healthy Male Subjects And Asthmatics |
| Official title | A Randomised, Double Blind, Placebo Controlled Study to Examine the Safety, Tolerability, Pharmacodynamics and Pharmacokinetic Profile of Single Inhaled Dry Powder Doses of GSK159802 in Healthy Male Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | GSK159802, Placebo, Salmeterol |
| Enrollment | 43 |
| Start date | Aug 24, 2005 |
| Primary completion | Jul 6, 2006 |
| Completion | Jul 6, 2006 |
| First posted | Aug 15, 2006 |
| Last update posted | Sep 29, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: